Abstract:C3 glomerulopathy (C3G) and atypical hemolytic uremic syndrome (aHUS) are two rare diseases caused by dysregulated activity of the alternative pathway of complement secondary to the presence of genetic and/or acquired factors. Complement factor I (FI) is a serine protease that downregulates complement activity in the fluid phase and/or on cell surfaces in conjunction with one of its cofactors, factor H (FH), complement receptor 1 (CR1/CD35), C4 binding protein (C4BP) or membrane cofactor protein (MCP/CD46). Because altered FI activity is causally related to the pathogenesis of C3G and aHUS, we sought to test functional activity of select CFI missense variants in these two patient cohorts. We identified 65 patients (16, C3G; 48, aHUS; 1 with both) with at least one rare variant in CFI (defined as a MAF < 0.1%). Eight C3G and eleven aHUS patients also carried rare variants in either another complement gene, ADAMTS13 or THBD . We performed comprehensive complement analyses including biomarker profiling, pathway activity and autoantibody testing, and developed a novel FI functional assay, which we completed on 40 patients. Seventy-eight percent of rare CFI variants (31/40) were associated with FI protein levels below the 25 th percentile; in 22 cases, FI levels were below the lower limit of normal (type 1 variants). Of the remaining nine variants, which associated with normal FI levels, two variants reduced FI activity (type 2 variants). No patients carried currently known autoantibodies (including FH autoantibodies and nephritic factors). We noted that while rare variants in CFI predispose to complement-mediated diseases, phenotypes are strongly contingent on the associated genetic background. As a general rule, in isolation, a rare CFI variant most frequently leads to aHUS, with the co-inheritance of a CD46 loss-of-function variant driving the onset of aHUS to the younger age group. In comparison, co-inheritance of a gain-of-function variant in C3 alters the phenotype to C3G. Defects in CFH (variants or fusion genes) are seen with both C3G and aHUS. This variability underscores the complexity and multifactorial nature of these two complement-mediated renal diseases.

Variation in Complement Factor H Affects Complement Activation in Immunoglobulin A Vasculitis with Nephritis.

Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy

Coding and Noncoding Variants in CFH Act Synergistically for Complement Activation in Immunoglobulin A Nephropathy.

Rare Variants in the Complement Factor H-Related Protein 5 Gene Contribute to Genetic Susceptibility to IgA Nephropathy.

A haplotype in CFH family genes confers high risk of rare glomerular nephropathies

Genetic Variant CFH Rs6677604 Might Play a Protective Role in Lupus Nephritis

The functional activities of complement factor H are impaired in patients with ANCA-positive vasculitis

Complement Factor H Variants Are Associated with Microangiopathy Lesions in IgA Nephropathy

Plasma Complement Factor H is Associated with Disease Activity of Patients with ANCA-associated Vasculitis

Fine Mapping Implicates a Deletion of CFHR1 and CFHR3 in Protection from IgA Nephropathy in Han Chinese.

Genetic association of complement factor B gene polymorphisms with susceptibility and prognosis of IgA nephropathy

Association of C-reactive Protein and Complement Factor H Gene Polymorphisms with Risk of Lupus Nephritis in Chinese Population

Implication of Urinary Complement Factor H in the Progression of Immunoglobulin A Nephropathy

Circulating complement factor H-related protein 5 levels contribute to development and progression of IgA nephropathy.

Mesangial C3 Deposition, Complement-Associated Variant, and Disease Progression in IgA Nephropathy

Complement Factor H Inhibits Anti-Neutrophil Cytoplasmic Autoantibody-Induced Neutrophil Activation by Interacting with Neutrophils

Complement Factor I Variants in Complement-Mediated Renal Diseases

Heterozygous mutations in factor H aggravate pathological damage in a stable IgA deposition model induced by Lactobacillus casei cell wall extract

Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy

Comprehensive Analysis of Complement Genes in Patients with Atypical Hemolytic Uremic Syndrome

A Functional Variant rs3093023 in CCR6 Is Associated With IgA Nephropathy by Regulating Th17 Cells in a North Han Chinese Population